SCHEMBL6178460

SCHEMBL6178460

CC(c1ccncc1NS(=O)(=O)Cc1ccccc1)C1(C(C)c2ccncc2NS(=O)(=O)Cc2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 4/20 0.38
METAP2 P50579 1/20 0.36
CXCR3 P49682 6/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
CCR9 P51686 2/20 0.34
FLT1 P17948 1/20 0.34
KDR P35968 1/20 0.34
ELANE P08246 1/20 0.34
CYP3A4 P08684 2/20 0.33
MAPK1 P28482 1/20 0.33
PTK2B Q14289 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174547 0.88 METAP2 (0.37) METAP2ALDH1A1ELANE
SCHEMBL6169571 0.86 CYP3A4 (0.35) LIPECXCR3ALDH1A1KDM4CCCR9
SCHEMBL6174307 0.86 CYP2C9 (0.38) LIPEALDH1A1CCR9FLT1KDR
SCHEMBL6173573 0.84 CACNA1H (0.41) CXCR3ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL6278206 0.84 TRPV1 (0.49) CXCR3ALDH1A1KDM5AKDM4CKDM5B
SCHEMBL6173283 0.82 CYP3A4 (0.38) LIPEALDH1A1KDM4CCCR9FLT1
SCHEMBL6173841 0.82 LIPE (0.41) LIPEMETAP2CXCR3ALDH1A1KDM5A
SCHEMBL6173837 0.82 LIPE (0.38) LIPEMETAP2ALDH1A1KDM5AKDM4C
SCHEMBL6174515 0.82 ALDH1A1 (0.45) ALDH1A1KDM4CCYP3A4TRPV1GAA
SCHEMBL6172844 0.81 CYP3A4 (0.40) CXCR3ALDH1A1KDM5AKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed